Dyne Therapeutics (DYN) PT Lowered to $36 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $17.12 +0.06%
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Morgan Stanley analyst Michael E Ulz lowered the price target on Dyne Therapeutics (NASDAQ: DYN) to $36.00 (from $45.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
- Lithia Motors (LAD) PT Lowered to $409 at Citi
- Teradata (TDC) PT Lowered to $32 at UBS on Cautious Q3 View
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
